Psychedelics at Work - Promise, Pitfalls and Murky Legality

Professionals are increasingly using psychedelics like LSD and magic mushrooms to try to improve work performance and creativity. The psychedelics market is expected to reach $11 billion by 2027.

People claim microdosing psychedelics boosts cognitive function and reduces anxiety, but placebo-controlled trials suggest it may not do much. Measuring doses precisely is difficult.

Some corporate executives attend expensive psychedelic retreats, hoping to return as more "conscious leaders" who can elevate their companies. But trips could make people question corporate jobs.

Team psychedelic retreats raise complicated questions around consent, pressure, and power dynamics in the workplace. Retreat leaders advise carefully considering personal boundaries.

While illegal, psychedelics are often seen as less risky career-wise than legal drugs like marijuana. But health and legal risks remain. Some experts warn people to understand all risks before using psychedelics for work.